Literature DB >> 28236093

Bone health in subjects with type 1 diabetes for more than 50 years.

Ernesto Maddaloni1,2, Stephanie D'Eon1, Stephanie Hastings1, Liane J Tinsley1, Nicola Napoli2, Mogher Khamaisi1, Mary L Bouxsein3, Savitri M R Fouda1, Hillary A Keenan4.   

Abstract

AIMS: Few data regarding prevalence of and risk factors for poor bone health in aging individuals with long-standing T1D are available. In this study, we aim to describe the prevalence of bone fragility and to identify factors associated with low bone density in individuals with long-term T1D.
METHODS: We examined the prevalence of non-vertebral fractures in 985 subjects enrolled in the Joslin 50-Year Medalist Study and measured bone mineral density (BMD) by dual-energy X-ray absorptiometry at the femoral neck, lumbar spine and radius in a subset (65 subjects, mean age 62.6 years, duration 52.5 years, HbA1c 7.1%) with no significant clinical or demographic differences from the rest of the cohort.
RESULTS: Medalists have low prevalence of fractures (0.20% hip and 0.91% wrist) and normal Z-score values (spine +1.15, total hip +0.23, femoral neck -0.01, radius +0.26; p > 0.05 for differences vs. 0 at all sites). A significant relationship was found between lower BMD and higher total cholesterol, triglycerides and LDL levels, but not HbA1c. Low BMD at the femoral neck was associated with cardiovascular disease after adjustment for confounding factors: prevalence risk ratio of CVD [95% CI] 4.6 [1.2-18.1], p = 0.03. No other diabetic vascular complication was found to be associated with low BMD.
CONCLUSIONS: These are the first data regarding bone health in aging individuals who have had diabetes for 50 or more years. The low rates of non-vertebral fractures and the normal Z-score suggest the long T1D diabetes duration did not increase the risk of bone fractures in Medalists compared to non-diabetic peers. Additionally, the association with cardiovascular disease demonstrates the BMD differences in groups are likely not due to glycemic control alone.

Entities:  

Keywords:  Aging; Bone fractures; Bone mineral density; Low bone mass; Osteoporosis; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28236093      PMCID: PMC5406751          DOI: 10.1007/s00592-017-0973-2

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  41 in total

1.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

Review 2.  Role of lipids in osteoporosis.

Authors:  F Parhami; A Garfinkel; L L Demer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

3.  Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women.

Authors:  Elsa S Strotmeyer; Jane A Cauley; Trevor J Orchard; Ann R Steenkiste; Janice S Dorman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

4.  A population-based study of bone mineral density in women with longstanding type 1 (insulin dependent) diabetes.

Authors:  H Lunt; C M Florkowski; T Cundy; D Kendall; L J Brown; J R Elliot; J E Wells; J G Turner
Journal:  Diabetes Res Clin Pract       Date:  1998-04       Impact factor: 5.602

5.  A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus.

Authors:  T Miazgowski; S Czekalski
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

6.  Decreased bone mineral density in subjects carrying familial defective apolipoprotein B-100.

Authors:  Laura M Yerges-Armstrong; Haiqing Shen; Kathleen A Ryan; Elizabeth A Streeten; Alan R Shuldiner; Braxton D Mitchell
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

7.  Factors influencing lumbar spine bone mineral density assessment by dual-energy X-ray absorptiometry: comparison with lumbar spinal radiogram.

Authors:  H Kinoshita; T Tamaki; T Hashimoto; F Kasagi
Journal:  J Orthop Sci       Date:  1998       Impact factor: 1.601

Review 8.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

9.  Cardiovascular disease protection in long-duration type 1 diabetes and sex differences.

Authors:  Zhiheng H He; Stephanie A D'Eon; Liane J Tinsley; Shane Fitzgerald; Stephanie M Hastings; Mogher Khamaisi; Jennifer K Sun; Sara J Turek; Ernst J Schaefer; George L King; Hillary A Keenan
Journal:  Diabetes Care       Date:  2015-05       Impact factor: 19.112

10.  A study of bone mineral density and its determinants in type 1 diabetes mellitus.

Authors:  Ameya Joshi; Premlata Varthakavi; Manoj Chadha; Nikhil Bhagwat
Journal:  J Osteoporos       Date:  2013-03-31
View more
  14 in total

1.  Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.

Authors:  Hema Kalyanaraman; Gerburg Schwaerzer; Ghania Ramdani; Francine Castillo; Brian T Scott; Wolfgang Dillmann; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  Diabetes       Date:  2018-01-04       Impact factor: 9.461

Review 2.  Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis.

Authors:  Silvia Pieralice; Francesca Vigevano; Rossella Del Toro; Nicola Napoli; Ernesto Maddaloni
Journal:  Curr Diab Rep       Date:  2018-08-18       Impact factor: 4.810

3.  Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.

Authors:  Eitan Halper-Stromberg; Tyler Gallo; Anagha Champakanath; Iman Taki; Marian Rewers; Janet Snell-Bergeon; Brigitte I Frohnert; Viral N Shah
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

Review 4.  Discoveries from the study of longstanding type 1 diabetes.

Authors:  Bruce A Perkins; Leif Erik Lovblom; Sebastien O Lanctôt; Krista Lamb; David Z I Cherney
Journal:  Diabetologia       Date:  2021-03-04       Impact factor: 10.122

5.  High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes.

Authors:  Ernesto Maddaloni; Yu Xia; Kyoungmin Park; Stephanie D'Eon; Liane J Tinsley; Ronald St-Louis; Mogher Khamaisi; Qian Li; George L King; Hillary A Keenan
Journal:  Cardiovasc Diabetol       Date:  2017-09-16       Impact factor: 9.951

6.  High Glucose Enhances the Odonto/Osteogenic Differentiation of Stem Cells from Apical Papilla via NF-KappaB Signaling Pathway.

Authors:  Yanping Wang; Yanqiu Wang; Yadie Lu; Jinhua Yu
Journal:  Biomed Res Int       Date:  2019-04-08       Impact factor: 3.411

Review 7.  Resistance Isn't Futile: The Physiological Basis of the Health Effects of Resistance Exercise in Individuals With Type 1 Diabetes.

Authors:  Olivia McCarthy; Othmar Moser; Max L Eckstein; Rachel Deere; Steve C Bain; Jason Pitt; Richard M Bracken
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

8.  Osteoporosis knowledge and beliefs in diabetic patients: a cross sectional study from Palestine.

Authors:  Ghaith A Ishtaya; Yazan M Anabtawi; Sa'ed H Zyoud; Waleed M Sweileh
Journal:  BMC Musculoskelet Disord       Date:  2018-02-07       Impact factor: 2.362

9.  Skeletal Status, Body Composition, and Glycaemic Control in Adolescents with Type 1 Diabetes Mellitus.

Authors:  Elzbieta Wierzbicka; Anna Swiercz; Pawel Pludowski; Maciej Jaworski; Mieczyslaw Szalecki
Journal:  J Diabetes Res       Date:  2018-09-03       Impact factor: 4.011

10.  FOXO1 Deletion Reverses the Effect of Diabetic-Induced Impaired Fracture Healing.

Authors:  Mohammed A Alharbi; Citong Zhang; Chanyi Lu; Tatyana N Milovanova; Leah Yi; Je Dong Ryu; Hongli Jiao; Guangyu Dong; J Patrick O'Connor; Dana T Graves
Journal:  Diabetes       Date:  2018-10-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.